Journal
JOURNAL OF GASTROINTESTINAL SURGERY
Volume 12, Issue 1, Pages 166-175Publisher
SPRINGER
DOI: 10.1007/s11605-007-0253-5
Keywords
esophageal adenocarcinoma; dynamic contrast-enhanced magnetic resonance imaging; neoadjuvant chemoradiation
Categories
Funding
- NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000422] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040801] Funding Source: NIH RePORTER
- NIBIB NIH HHS [R01 EB00422] Funding Source: Medline
- NINDS NIH HHS [R01 NS40801] Funding Source: Medline
Ask authors/readers for more resources
Although neoadjuvant chemoradiation eradicates esophageal adenocarcinoma in a substantial proportion of patients, conventional imaging techniques cannot accurately detect this response. Dynamic contrast-enhanced magnetic resonance imaging is an emerging approach that may be well suited to fill this role. This pilot study evaluates the ability of this method to discriminate adenocarcinoma from normal esophageal tissue. Patients with esophageal adenocarcinoma and control subjects underwent scanning. Patients treated with neoadjuvant therapy underwent pre- and postchemoradiation scans. Parameters were extracted for each pixel were K-trans (equilibrium rate for transfer of contrast reagent across the vascular wall), v(e) (volume fraction of interstitial space), and tau(i) (mean intracellular water lifetime). Five esophageal adenocarcinoma patients and two tumor-free control subjects underwent scanning. The mean K-trans value was 5.7 times greater in esophageal adenocarcinoma, and tau(i) is 2.0 times smaller, than in the control subjects. K-trans decreased by 11.4-fold after chemoradiation. Parametric maps qualitatively demonstrate a difference in K-trans. DCE MRI of the esophagus is feasible. K-trans, a parameter that has demonstrated discriminative ability in other malignancies, also shows promise in differentiating esophageal adenocarcinoma from benign tissue. The determination of K-trans represents an in vivo assay for endothelial permeability and thus may serve as a quantitative measure of response to induction chemoradiation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available